|
(b)(4).An incoming inspection was performed on product # 26746, lot #240401 following sop-11 incoming inspection procedure.This lot met the the inspection criteria for product release, with no abnormalities noted.The cmo conducted an investigation that included the following:production process review: the batch production review and finished product release inspection report for this batch were reviewed.There were no changes in raw materials or production process, and the finished product passed the release inspection.No non conformities were observed.Retained sample testing:appearance inspection: ten (10) retained samples from this lot were tested for visual or appearance inspection.All tested samples complied with the requirements, and all components of the product were properly assembled without ay detachment or damage observed.Seal integrity testing: five (5) samples were selected for seal integrity testing.All tested samples complied with the test criteria, with no air leakage noted.Simulated clinical testing: five (5) samples were selected for simulated clinical testing.All tested samples met the requirements for simulation tests, and no liquid leakage was found.Cause analysis based on the photos submitted, the following possible scenario may have occurred.The needle hub may have been accidentally pulled out during clinical use, creating a gap between the catheter and the needle.This could have allowed blood to flow from the peripheral catheter into the catheter hub, resulting in blood leakage.The peripheral hub assembly may have been damaged which could also lead to a blood leakage.However, these causes could not be confirmed due to the absence of the defective device to examine.Based on available information, we were unable to determine the root cause, and/or unable to replicate the issue in our investigation.Therefore, the root cause remains unconfirmed.This complaint can now be closed.No similar complaints found in the lot.
|